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A model that explains how maintenance of normal homeostasis in human epidermis is achieved describes a
heterogeneous cell population of stem cells (SC) and transit amplifying cells (TAC). There must be a tightly reg-
ulated balance between SC self-renewal and the generation of TAC that undergo a limited number of divisions
before giving rise to postmitotic, terminally differentiated cells. To investigate whether this balance is disturbed in
psoriatic epidermis, we have characterized ﬂow sorted enriched SC and TAC using immunocytochemistry, ﬂow
cytometry, and real-time quantitative PCR. Our data demonstrate phenotypical and functional differences in SC (b1-
integrin bright) and TAC (b1-integrin dim) enriched fractions between normal and psoriatic keratinocytes. Some of
these were expected, such as mRNA levels of keratins 6 and 10 and of the Ki-67 antigen. Most remarkable were
differences in phenotype of the psoriatic TAC compared with TAC from normal skin. These subpopulations also
displayed striking differences following culture. Downregulation of markers associated with the regenerative phe-
notype (psoriasin, elaﬁn, psoriasis-associated fatty acid binding protein) in cultured psoriatic dim cells in the
absence of hyperproliferation suggests that proliferation and regenerative maturation are coupled. From these
results, in combination with our earlier ﬁndings, we propose a model for epidermal growth control in which TAC
play a crucial role.
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The epidermis is a stratified squamous epithelium, which is
under a constant state of proliferation, terminal differentia-
tion, and elimination. In this way the functional integrity of
the tissue is sustained. The intact epidermis has the ability
to respond to a diversity of environmental stimuli, and by
continuous turnover it can maintain its normal homeostasis.
The processes involved and the mechanisms by which the
epidermal stem cells (SC) differentiate are largely unknown.
An accepted model that explains how maintenance of nor-
mal homeostasis is achieved describes a heterogeneous
germinative cell population of SC and more differentiated
transit amplifying cells (TAC) (Jones et al, 1995; Jones,
1997; Watt, 2002).
Using fluorescence activated cell sorting, basal cells can
be sorted into SC-enriched fractions, which strongly ex-
press b1-integrins (bright cells) and fractions enriched for
TAC that display only a weak b1-integrin expression (dim
cells) (Jones and Watt, 1993; Jones et al, 1995; Jones,
1997). Apart from the b1-integrin family, several markers
have been suggested as indicative for the epidermal SC or
the TAC (reviewed by Potten and Booth, 2002). It was
shown that the transcription factor p63 was abundantly ex-
pressed in holoclones, which are believed to contain SC,
whereas it was greatly reduced in meroclones that are
formed by ‘‘young’’ TAC and undetectable in paraclones
consisting of terminal colonies prone to differentiate (Pelle-
grini et al, 2001). The expression pattern of the a6-integrin
has revealed no differences between SC and TAC, but
combining the a6-integrin expression with the transferrin
receptor (10G7 antigen, later known as CD71) expression,




tively (Li et al, 1998; Tani et al, 2000). Furthermore, using
proteomics on b1-integrin bright and dim cells, the psoria-
sis-associated fatty acid binding protein (PA-FABP) was
found to be upregulated in the transit amplifying fraction
(O’Shaughnessy et al, 2000).
Although several markers have been proposed, the ker-
atinocyte SC and its daughter, the TAC are still poorly de-
fined. One function of the TAC is to amplify the number of
cells derived from asymmetric cell division by SC to allow
sufficient cell production for terminal differentiation and for-
mation of skin barrier. In this way, SC can divide infrequently
and still the terminal differentiation compartment is replen-
ished. It has always been assumed that SC when not di-
viding were held in the G0/G1 phase of the cell cycle, but no
direct evidence to prove this hypothesis has been pub-
lished, partly because isolating a pure isolation of SC was
problematic (Dunnwald et al, 2003). With respect to the TAC
Abbreviations: FITC, fluorescein isothiocyanate; PA-FABP, psoria-
sis-associated fatty acid binding protein; SC, stem cell; TAC, tran-
sit amplifying cell
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of the epidermis, research is even more limited. It is gen-
erally accepted that as soon as cells leave the SC com-
partment, they are committed to terminal differentiation.
This process is considered to be continuous and irrevers-
ible.
In normal epidermis, the majority of basal germinative
cells are quiescent and only a small fraction is proliferating.
In psoriasis, a chronic skin disease of yet unknown etiology,
which is characterized by epidermal hyperproliferation and
regenerative maturation (Mansbridge et al, 1984), most ger-
minative cells are proliferating. This regenerative phenotype
has been thoroughly studied previously and includes the
expression of the differentiation markers keratin (K) 6, K16
(Leigh et al, 1995), psoriasin (Madsen et al, 1991), elafin
(Schalkwijk et al, 1990), and PA-FABP (Madsen et al, 1992;
Masouye et al, 1996; Watanabe et al, 1997). It is generally
estimated that SC constitute between 1% and 10% of the
basal layer (Potten and Morris, 1988), and as approximately
40% of the basal layer exhibits high levels of b1-integrin
(Jones et al, 1995), it is likely that these basal cells contain a
small number of SC and a significant number of TAC. In fact,
in psoriasis the b1-integrin expression is increased and b1-
integrin-positive cells are also seen in the suprabasal layers
(Hertle et al, 1992; Watt and Jones, 1993). Using mathe-
matical models, the typical psoriatic histology was ex-
plained as a result of a markedly increased proliferative
compartment (Watt and Hertle, 1994; Iizuka et al, 1996;
Iizuka et al, 1997). The mechanisms that drive the keratin-
ocyte hyperproliferation in psoriasis are largely unknown. It
is not known whether the defect in growth control is at the
level of the SC or the TAC, or both. In lesional psoriatic
epidermis, a large number of cells are cycling both in the
basal and the first suprabasal layers. Clearly, the TAC com-
partment has expanded enormously in psoriasis, giving rise
to a huge cell production rate and the ensuing scaling
process. A number of antipsoriatic therapies are directed at
suppressing keratinocyte growth, e.g., directly, or indirectly
by acting at the level of the T cell, but it is not known how
antipsoriatic agents exert their antiproliferative effects. They
could act at the level of the SC by suppressing the gen-
eration of daughter cells, or alternatively they could act at
the level of the TAC. Even at this point several possibilities
exist: antipsoriatic agents could drive basal TAC to the G0
phase of the cell cycle by interfering with a vicious (auto-
crine) loop, or inhibit proliferation of late TAC in the supra-
basal layer, or promote normal differentiation of the
suprabasal compartment. Clearly, a better knowledge on
the heterogeneity and functional characteristics of germi-
native subpopulations in the psoriatic epidermis is required
to understand the basic abnormalities of the disease, and
the mode of action of antipsoriatic agents.
On the basis of previous studies, we hypothesized that
early cell kinetic changes observed in the TAC population in
healing or exacerbating hyperproliferative skin are of path-
ogenic significance (Rijzewijk et al, 1992; Castelijns et al,
1999; Franssen et al, 2004). The aim of this study was to
extend these investigations and compare flow-sorted b1-
integrin dim (assumed transit amplifying) cells and b1-inte-
grin bright (putative stem) cells from normal and psoriatic
skin. Using real-time quantitative (qPCR), we analyzed
mRNA levels of b1-integrin dim and bright cells that were
derived from normal and psoriatic epidermis by flow sorting
of freshly isolated cells. To establish whether these sub-
populations differ with respect to growth behavior and col-
ony morphology, and whether cellular characteristics are
maintained in vitro, the b1-integrin dim and bright sub-
populations from normal and psoriatic epidermis were cul-
tured and analyzed similarly at the protein and mRNA level.
From these results, in combination with our earlier findings,
we propose a model for epidermal growth in which TAC play
a crucial role.
Results
Characterization of ﬂow-sorted epidermal subpopulat-
ions from normal and psoriatic epidermis by qPCR Sev-
eral studies have previously described a different protein or
gene expression profile in b1-integrin bright and dim frac-
tions of normal human epidermis. Here, we have examined
flow sorted b1-integrin bright and dim fractions from psoria-
tic epidermis, and compared these with the subpopulations
in normal epidermis using qPCR. Although the expression
pattern of b1-integrin at the protein level allows a clear sep-
aration between bright and dim keratinocytes (Fig 1), normal
keratinocytes revealed only a slightly elevated mRNA level
of b1-integrin in the bright keratinocytes, whereas there was
a 2-fold elevated mRNA level in psoriatic bright keratin-
ocytes compared with the dim fraction (po0.05) (Fig 2A).
Figure1
Flow sorting of b1-integrin-positive subpopulations. As depicted, a
dot plot representing cell size (FS)/CD29-fluorescein isothiocyanate
(FITC) fluorescence per cell allows a clear separation between the b1-
integrin-negative and the b1-integrin-positive population. Based on the
mean CD29-FITC fluorescence, gates can then be set in the b1-inte-
grin-positive population; approximately 10% of the cells with the high-
est b1-integrin expression are defined as bright cells and 10% of the
cells with the lowest b1-integrin expression are identified as dim cells.
In this way, it was possible to prevent overlap between both sub-
populations, and rather selective subpopulations of each cell type were
obtained for further experiments.
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mRNA levels of a6-integrin, which is the partner subunit for
b4-integrin in the hemidesmosome, were similar for both the
normal b1-integrin bright and dim keratinocytes, whereas
the psoriatic b1-integrin bright cells showed 3-fold higher
levels compared to the psoriatic dim keratinocytes (po0.05)
(Fig 2A). No differences in b4-integrin mRNA levels were
found between bright and dim cells, irrespective of the tis-
sue from which they were obtained (Fig 2A). mRNA levels of
the epidermal differentiation marker K10 were higher in the
b1-integrin dim fraction of both normal (2-fold) and psoriatic
(7-fold, po0.01) keratinocytes compared with the bright
fractions. K6 mRNA levels were, as expected, virtually un-
detectable in both fractions of normal keratinocytes, where-
as both psoriatic b1-integrin bright and dim keratinocytes
showed elevated levels of K6 mRNA (po0.001). Again,
there was a major difference between psoriatic b1-integrin
bright and dim cells, with a 3-fold higher mRNA level in the
psoriatic dim cells (po0.001, data not shown). As a meas-
ure of proliferative activity, the Ki-67 mRNA levels were
examined, and as expected, these were relatively low in
normal b1-integrin bright and dim keratinocytes although
the level in the dim cells was 3-fold higher than in the bright
cells (po0.05). In psoriatic keratinocytes, a 5-fold higher
level of Ki-67 mRNA was seen in both the dim and bright
fraction compared with the normal keratinocytes (po0.05)
(Fig 3A). Although the transferrin receptor (CD71) has been
suggested as a marker for TAC, in our hands, mRNA levels
were almost identical in normal b1-integrin bright and dim
keratinocytes, with slightly elevated levels in both the
psoriatic fractions compared with the normal subpopulat-
ions (Fig 4A). Remarkably, the mRNA levels of the putative
SC marker p63 revealed a 2-fold higher level in normal b1-
integrin bright cells compared with normal b1-integrin dim
cells, whereas no differences were found between the
psoriatic dim and bright keratinocytes. Surprisingly, mRNA
levels for collagen VII revealed a similar trend as the p63
levels, with an even stronger difference between the levels
measured in b1-integrin bright keratinocytes compared with
b1-integrin dim keratinocytes for both normal (NS) and
psoriatic skin (po0.05) (Fig 4A). Finally, we analyzed a
number of markers that are associated with abnormal dif-
ferentiation in psoriatic epidermis. These include elafin and
psoriasin, which are not expressed in normal skin, and PA-
FABP, which shows a restricted (stratum granulosum) ex-
pression in normal skin. In the upper suprabasal layers of
psoriatic epidermis, high expression levels of elafin, psoria-
Figure 2
Integrin mRNA expression in germinative epidermal subpopulat-
ions. mRNA quantitation (y-axis) was obtained relative to the reference
gene human acidic ribosomal protein P0 according to the method of
Livak (Livak and Schmittgen, 2001). (A) mRNA levels of b1- (black bars),
a6- (gray bars), and b4-integrin (white bars) in flow-sorted fractions of
bright and dim cells obtained from normal and psoriatic epidermis. (B)
mRNA levels of b1-, a6-, and b4-integrin in cultured bright and dim cells
derived from normal and psoriatic epidermis. Note the low levels of
expression of all integrins in cells cultured from psoriatic dim cells.
Results of sorted cells represent mean values  SEM of three different
patients, whereas cultured cells were based on four samples. NS, nor-
mal skin; PS, psoriatic skin.
Figure3
Ki-67 mRNA expression in germinative epidermal subpopulations.
mRNA quantitation (y-axis) was obtained relative to the reference gene
human acidic ribosomal protein P0 according to the method of Livak
(Livak and Schmittgen, 2001). (A) Ki-67 levels (black bars) were nearly
undetectable in flow-sorted normal cells; substantially higher levels
were found in psoriatic cells. (B) In vitro, Ki-67 levels showed a strong
increase in normal cells compared with freshly isolated cells; psoriatic
bright and dim cells showed a strong decrease compared with freshly
isolated cells. Results of sorted cells represent mean values  SEM of
three different patients, whereas cultured cells were based on four
samples. NS, normal skin; PS, psoriatic skin.
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sin, and PA-FABP are found. As expected, normal keratin-
ocytes revealed no detectable mRNA levels of these tran-
scripts, whereas expression levels in psoriatic keratinocytes
revealed a strong expression of PA-FABP (po0.01, 5-fold),
psoriasin (2-fold), and skin-derived anti leucoprotease
(SKALP)/elafin (po0.01, 5–6-fold) in the psoriatic b1-inte-
grin dim keratinocytes compared with the psoriatic bright
cells (Fig 5A). These findings suggest that transcripts as-
sociated with regenerative maturation are already present in
the TAC population. Additionally, the expression levels of
transcripts involved in cell cycle control were examined,
including the Cdk inhibitory proteins p16, p21, and p27,
which are believed to suppress G1/S Cdk activity, and ma-
spin, a recently discovered tumor suppressor that is be-
lieved to be upregulated in keratinocyte senescence. To
establish whether these transcripts were already upregu-
lated in the b1-integrin bright and dim subpopulations, the
expression levels of p16, p21, p27, and maspin were ex-
amined, and as expected they were low in all fractions im-
mediately after sorting (Fig 8A).
Phenotypical characterization of keratinocytes cultured
from normal and psoriatic skin To examine whether dif-
ferences found in freshly isolated keratinocytes are main-
tained in culture, and whether these are associated with
different growth behavior and morphology, b1-integrin bright
and dim keratinocytes were flow sorted and seeded on a
feeder layer of 3T3 cells that supports colony formation
(Rheinwald and Green, 1975). Approximately 6 d after
seeding, the first colonies could be detected in the b1-in-
tegrin bright and dim cultures of normal keratinocytes,
whereas the cultures from psoriatic keratinocytes did not
show any colonies until day 8 or 9 after seeding. In normal
keratinocytes, a subconfluence of 60% was reached after
approximately 15 d, whereas confluence was reached after
22 d. On the other hand, psoriatic cultures did not reach
60% confluence until approximately 22 d and confluence
at 29 d after seeding. Remarkably, confluency was only
achieved in the cultures derived from the psoriatic b1-
integrin bright keratinocytes, whereas cultures derived
from psoriatic b1-integrin dim keratinocytes showed
Figure 4
CD71, collagen type VII, and p63 mRNA expression in germinative
cell populations. mRNA quantitation (y-axis) was obtained relative to
the reference gene human acidic ribosomal protein P0 according to the
method of Livak (Livak and Schmittgen, 2001). (A) CD71, a putative
transit amplifying cell marker (black bars) and p63, a putative stem cell
marker (gray bars), did not provide a clear discrimination of b1-integrin
bright and dim cells sorted from normal and psoriatic epidermis. Col-
lagen VII (white bars), however, was consistently higher in b1-integrin
bright cells compared with dim cells. (B) CD71 is strongly upregulated
in cultured cells. All three markers show low expression levels in cul-
tured psoriatic dim cells compared with the other cultured cell pop-
ulations. Results of sorted cells represent mean values  SEM of three
different patients, whereas cultured cells were based on four samples.
NS, normal skin; PS, psoriatic skin.
Figure5
Elafin, psoriasin, and psoriasis-associated fatty acid binding pro-
tein (PA-FABP) mRNA expression in germinative epidermal sub-
populations. mRNA quantitation (y-axis) was obtained relative to the
reference gene human acidic ribosomal protein P0 according to the
method of Livak (Livak and Schmittgen, 2001). (A) mRNA levels of PA-
FABP (black bars), psoriasin (gray bars), and elafin (white bars) in flow-
sorted fractions of bright and dim cells were virtually undetectable in
keratinocytes derived from normal skin, and were high in the dim frac-
tions derived from psoriatic skin. (B) In vitro, a strong increase of all
three transcripts was found in cultured normal keratinocytes compared
with flow-sorted cells. In cultured psoriatic dim cells, PA-FABP and
psoriasin were downregulated compared with flow-sorted cells. Elafin
expression was remarkably lower in cultured psoriatic cells compared
with cultured normal cells. Results of sorted cells represent mean val-
ues  SEM of three different patients, whereas cultured cells were
based on four samples. NS, normal skin; PS, psoriatic skin.
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predominantly small abortive colonies (presumed para-
clones) with a pronounced keratinization in the center of
the colony (Fig 6). The b1-integrin bright colonies revealed
considerably less keratinization and showed an increase in
size over time until confluency was reached. The psoriatic
b1-integrin dim colonies did not increase in size any further
and neither did they reach confluency, not even after 29 d.
This phenomenon was rarely observed in cultures of normal
keratinocytes.
For cytochemical analysis, we seeded flow-sorted ker-
atinocytes on coverslips and the cells were cultured as in-
dicated above. Subsequently, staining for a number of
integrins and differentiation markers was performed. Figure
7 shows cytokeratin 10 and 6 expression in cultured normal
keratinocytes at 14 d after seeding. A marked difference
was noted between dim and bright cells, both in normal and
psoriatic skin (data not shown). For most markers, however,
quantification of positive cell numbers and staining intensity
was virtually impossible. To enable quantification, we used
multiparameter flow cytometry on cell suspensions ob-
tained from cultures mentioned above. Cells were grown
until approximately 60% and 100% confluency and subse-
quently harvested and stained for flow cytometric analysis.
Independent of their origin, all cells in suspension were
similar with respect to cell size and shape (flow cytometric
forward scatter and side scatter, respectively). Furthermore,
no striking differences in protein expression were found
between 60% and 100% confluency. In vitro normal kera-
tinocytes nearly all express the b1-, b4-, and a6-integrin, the
Ki-67 antigen, and the transferrin receptor, indicating a
strong upregulation of these proteins in cultured cells. But,
only 20%–30% of the psoriatic dim keratinocytes ex-
pressed these proteins, whereas the bright fraction showed
intermediate percentages (data not shown). The number of
cells expressing the differentiation markers K10 and K6 re-
mained relatively low under the culture conditions used.
Nevertheless, the expression of these keratins appeared
consistently higher in cultures derived from b1-integrin dim
cells compared with cultures derived from b1-integrin bright
cells, which is in accordance with the cytochemical findings
(see Fig 7). Collagen VII and p63 expression were also
strongly downregulated under the conditions used, hinder-
ing an accurate quantification (data not shown).
Finally, we examined a number of genes at the mRNA
level in cultured b1-integrin bright and dim cells from normal
and psoriatic epidermis as described above. The normal-
ized expression levels are shown in Figs 2B, 3B, 4B, and 5B
and can be used for comparison with the expression levels
in freshly isolated cells (shown in Figs 2A, 3A, 4A, and 5A).
The differences in b1-integrin mRNA levels in the cells that
were sorted on the basis of b1-integrin immunostaining
Figure 6
Morphology of keratinocyte colonies. Seventeen days after seeding,
the psoriatic bright cultures consisted of large colonies with minimal
keratinization that reached confluency within 1 mo (A); cultures of
psoriatic dim cells showed, however, predominantly small abortive
colonies with a markedly keratinized center (B). Similar differences
were found less frequently in cultures derived from normal skin (data
not shown).
Figure7
Immunocytochemical staining of cultured keratinocytes.
Immunocytochemical staining of normal keratinocytes cultured on cov-
erslips revealed differences in keratin (K) 10 expression (A and B) and
K6 expression (C and D) between the b1-integrin bright (A and C) and
the b1-integrin dim (B and D) fraction. Notice the strong K10 and K6
expression in the dim fraction (similar staining patterns were observed
in psoriatic cultures; data not shown).
GERMINATIVE EPIDERMAL SUBPOPULATIONS 377124 : 2 FEBRUARY 2005
were similar for freshly isolated and cultured keratinocytes.
Keratinocytes from the b1-integrin bright fraction in psoriatic
epidermis, however, showed a marked increase compared
with the freshly isolated cells. Figures 2B and 3B show that
cells cultured from the dim fraction of psoriatic epidermis
express significantly less a6-integrin, b4-integrin (po0.05),
and Ki-67 (po0.05), compared with freshly isolated dim
cells from psoriatic lesions. This is in contrast to the dim cell
population cultured from normal skin, which showed an in-
crease of a6-integrin (po0.05), CD71 (po0.01), and Ki-67
(Figs 2B, 3B, and 4B). The cell populations cultured from
bright cells of normal skin and psoriatic skin showed similar
expression profiles. When compared with the freshly iso-
lated cells, a strong increase of CD71 was noted in both the
cultured bright cell populations (po0.01). The putative SC
marker p63, on the other hand, showed a strong decrease
in all cultured subpopulations, irrespective of the subpop-
ulation and tissue from which they were cultured. A similar
phenomenon was noticed for the collagen VII mRNA levels
(Fig 4B), and the marker for epidermal differentiation K10
(data not shown). The mRNA levels of K6 showed a strong
decrease in the dim cells cultured from psoriatic skin,
whereas an unchanged level was noted in the psoriatic
bright cells. The cell populations cultured from normal skin
showed a strong increase of K6 under these culture con-
ditions (data not shown). A marked difference was seen with
respect to Ki-67 expression; cultured bright cells from nor-
mal skin showed a strong increase, whereas a strong de-
crease of Ki-67 was noted in cultured bright cells from
psoriatic skin, when compared with the expression levels in
freshly isolated cells (Fig 3A, B). These data reveal a sub-
stantial difference between germinative cell populations
from normal and psoriatic skin.
Figure 5A, B shows the expression levels of genes that
are associated with aberrant differentiation in psoriasis (ela-
fin, psoriasin, PA-FABP). A strong induction of all three
markers was found in both cell populations cultured from
normal skin, indicating the well-known phenomenon that
keratinocytes from normal skin can acquire the regenerative
maturation phenotype in cell culture. Remarkably, only a
modest induction was seen in psoriatic bright cells, and
a decrease in expression of psoriasin (NS) and PA-FABP
(po0.01) was noted in the dim cells. Again, this indicates
the marked differences between the germinative cell pop-
ulations of normal and psoriatic epidermis. Additionally, the
expression levels of p16, p21, p27, and maspin were ex-
amined in the cultured subpopulations. The low expression
levels of p21 did not change appreciably during the culture
period. Maspin showed no significant differences in the ex-
pression levels in sorted cells and again not in the cultured
subpopulations. The expression levels of p27 (NS) showed
a marked increase in the cultured subpopulations; however,
no significant differences in expression were noticed be-
tween the b1-integrin bright and dim fractions of both nor-
mal skin and psoriatic skin. The expression level of p16
showed an increase in the cultured fractions of normal and
psoriatic cells (Fig 8A, B), with a strong increase in the ex-
pression levels measured in the bright fraction of both nor-
mal (po0.01) and psoriatic (po0.01) skin. But, significant
differences were only noted between the bright and dim
fraction of psoriatic skin (po0.05).
Discussion
This study provides evidence that flow-sorted b1-integrin
dim (assumed transit amplifying) cells and b1-integrin bright
(putative stem) cells from normal and psoriatic skin are
phenotypically and functionally different. From their growth
behavior in culture, we conclude that psoriatic TAC are
more advanced in their life cycle than the dim cells in normal
skin. Furthermore, the strong downregulation of marker
genes for regenerative maturation (psoriasis-related differ-
entiation markers) in the cultured psoriatic dim cells in the
absence of hyperproliferation suggests that proliferation
and regenerative maturation/differentiation are coupled
processes.
Since Jones and Watt demonstrated that high levels of
the a2b1 (a receptor for collagens and laminins), a3b1 (a re-
ceptor for laminins and epiligrin), and a5b1 integrin (a
receptor for fibronectin) can distinguish SC from TAC and
postmitotic differentiating cells in cultured human epidermis
(Jones and Watt, 1993; Jones et al, 1995), b1-integrin ex-
pression has been used to isolate b1-integrin bright and b1-
integrin dim cells by fluorescence activating cell sorting.
Figure8
p16 mRNA expression in germinative epidermal subpopulations.
mRNA quantitation (y-axis) was obtained relative to the reference gene
human acidic ribosomal protein P0 according to the method of Livak
(Livak and Schmittgen, 2001). (A) p16 levels (black bars) were nearly
undetectable in flow-sorted normal and psoriatic cells. (B) In vitro, p16
levels showed an increase in normal and psoriatic cells compared with
freshly isolated cells; note the strong increase in the psoriatic bright
cells. Results of sorted cells represent mean values  SEM of three
different patients, whereas cultured cells were based on four samples.
NS, normal skin; PS, psoriatic skin.
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This method allowed in vitro studies on fractions enriched
for each cell type (Fig 1). But, high b1-integrin expression
marks approximately 25%–40% of the basal cells, whereas
SC are estimated to comprise less than 10% of the basal
cells (Jones et al, 1995). In psoriasis, b1-integrin expression
is not only confined to the basal layer but has also extended
to the suprabasal layers (Hertle et al, 1992; Watt and Jones,
1993). In fact, it has even been suggested that suprabasal
expression of integrins could be a pathogenic factor in
psoriasis (Carroll et al, 1995). In this study, we therefore
investigated the in vivo and in vitro characteristics of b1-
integrin bright and b1-integrin dim keratinocytes derived
from normal and psoriatic skin biopsies.
After inoculation of b1-integrin bright and dim keratin-
ocytes, the first colonies were observed around day 6 in
cultures derived from normal skin and at approximately day
8 or 9 in cultures derived from psoriatic skin. In normal cul-
tures, 60% confluence was reached after 15 d and 100%
confluence at approximately 22 d. Remarkably, psoriatic
cultures had only reached 60% confluence at 22 d after
plating, suggesting a decreased proliferative activity com-
pared with normal keratinocytes. In fact, the psoriatic b1-
integrin dim colonies did not reach confluence at all during
the entire culture period of 30 d. Each well revealed only a
few colonies, of which the majority was abortive, showing a
keratinized centre (Fig 6). Subcloning studies of Barrandon
and Green (1987) allowed classification of cultured keratin-
ocyte clones into three different types. First, the holoclone
was distinguished by a high reproductive capacity in the
absence of terminal differentiation. Second, a paraclone
consisted of cells that stopped dividing after a few rounds
of mitosis and underwent terminal differentiation. And final-
ly, meroclones were a mixture of cells of different growth
potential, representing a transitional stage between a holo-
clone and a paraclone (Barrandon and Green, 1987). In our
study, cultures from normal b1-integrin bright and dim
keratinocytes showed colonies resembling predominantly
holoclones and meroclones, whereas the psoriatic keratin-
ocytes, on the other hand, revealed colonies resembling
holo- or meroclones in the b1-integrin bright cultures, and
predominantly paraclones in the b1-integrin dim cultures
(Fig 6). These findings suggest that psoriatic TAC are more
advanced in their life cycle than the dim cells in normal skin,
although both fractions were sorted alike on their low ex-
pression of the b1-integrin.
Bata-Csorgo et al (1993) observed increased numbers
and hyper-responsiveness of CD29 (b1-integrin)
þ K1/10
cells in psoriatic compared with normal epidermis (Bata-
Csorgo et al, 1993). These findings were attributed to SC
hyperproliferation (Bata-Csorgo et al, 1995). It is also pos-
sible, however, that this abnormality is the result of an in-
creased activity of ‘‘young’’ TAC, being cells that have just
left the stem cell compartment. Furthermore, the relative
proportions of CD29þ K1/10 and CD29þ K1/10þ cells
proved similar in normal and psoriatic epidermis (Bata-
Csorgo et al, 1993), suggesting accelerated maturation of
newly formed TAC, followed by loss of the CD29 label.
Comparison of our results with these findings suggests that
the SC hyperproliferation or the increased activity of young
TAC in the psoriatic epidermis leads to an accelerated mat-
uration of the latter cells, explaining the decrease of their
proliferative activity in vitro compared with the dim cells in
normal skin. In fact, in our previous work, an assessment of
b1-integrin bright and b1-integrin dim cells derived from
normal skin biopsies showed that the total number of col-
onies formed and the initial growth rate of the colonies were
higher in the b1-integrin dim cells than in the b1-integrin
bright subpopulation (van Rossum et al, 2004). These find-
ings are more in line with the fact that TAC have a greater
initial proliferative rate, at least in normal skin.
With respect to the mRNA levels of the b1-integrin, no
differences in the expression levels of b1-integrin were
found comparing the bright and the dim cells of normal skin,
despite the protein differences. In the psoriatic dim cells,
however, the mRNA levels were markedly downregulated.
During culture, a small increase of the initial level was seen
in the b1-integrin bright cells of normal and psoriatic skin
and in the b1-integrin dim cells of normal skin, whereas the
levels in the psoriatic b1-integrin dim cells remained low
(Fig 2A, B). Since downregulation of the b1-integrin protein
is associated with the onset of terminal differentiation
(Adams and Watt, 1990; Hotchin and Watt, 1992; Hotchin
et al, 1993, 1995; Watt and Hertle, 1994), the low mRNA
levels detected in the psoriatic dim cells suggest a strong
commitment to terminal differentiation. In fact, we found
even lower mRNA levels in the psoriatic dim cells compared
with the normal dim cells, again suggesting that the psoria-
tic TAC are ahead in their life cycle compared with their
normal counterparts.
Expression of the b1-integrin protein is not correlated
with its functional state (Penas et al, 1998). In fact, in pso-
riasis, the suprabasal b1-integrins were found to be in an
inactive state, and the basal integrins mostly in a nonactive
confirmation, suggesting that active b1-integrins might be
related to inhibition of proliferation, whereas inactive
epitopes result in hyperproliferation in vivo. Indeed, when
examining the levels of Ki-67 expression, we found virtually
undetectable levels in normal keratinocytes, and 5-fold
higher levels in psoriatic keratinocytes. In vitro, a strong
upregulation of the Ki-67 level was seen in normal cells,
whereas we noticed a strong downregulation in psoriatic
keratinocytes and particularly in the psoriatic dim cells. This
was confirmed by flow cytometric analysis of cultured ker-
atinocytes, showing only 20% Ki-67-positive cells in the
psoriatic dim fraction, whereas nearly all cells were Ki-67-
positive in both normal fractions and approximately 50% in
the psoriatic bright fraction. Similar results were found for
the hyperproliferation-related keratin 6; as expected no ex-
pression was found in normal keratinocytes, but the psoria-
tic keratinocytes revealed a 3-fold higher mRNA level
in psoriatic dim cells compared with bright cells. Cultured
normal keratinocytes showed an upregulation, whereas
psoriatic dim cells showed a 6-fold downregulation. Once
more illustrating that although the psoriatic TAC are hyper-
proliferative in vivo, this phenotype ceases almost instantly
in vitro, whereas the normal dim cells are still able to pro-
liferate a number of times in culture.
The p63 transcription factor was suggested as a marker
for SC, since it was abundantly expressed in holoclones but
undetectable in paraclones (Pellegrini et al, 2001). In fact,
mRNA levels showed highest expression in both the normal
as the psoriatic bright cells, which is in keeping with this
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study. In our culture system, however, p63 levels were
strongly downregulated in all subpopulations (Fig 4A, B).
Remarkably, freshly prepared normal and psoriatic keratin-
ocytes revealed similar mRNA levels for collagen VII as seen
for p63, again with a low expression in vitro. Flow cytometric
analysis of b1-integrin-positive keratinocytes displayed a
small population of b1-integrin bright and collagen VII bright
cells with a low side-scatter phenotype. As these cells ac-
counted for approximately 1%–2% of the cells measured,
and both b1-integrin and collagen VII are expressed in basal
keratinocytes; obviously, these b1-integrin bright/collagen
VII bright cells necessitate further investigation and collagen
VII might be a new potential SC marker.
Finally, we examined the b1-integrin bright and b1-inte-
grin dim fractions of psoriatic skin for their expression levels
of genes associated with regenerative maturation (Fig 5A,
B). As expected, freshly prepared normal keratinocytes re-
vealed undetectable mRNA levels of PA-FABP, psoriasin,
and elafin. Psoriatic dim keratinocytes on the other hand,
showed significantly higher mRNA levels of all three mol-
ecules compared with the levels detected in the psoriatic
bright keratinocytes. Using 2D gel electrophoresis and
northern blotting, a 2-fold upregulation of PA-FABP was
found in the b1-integrin dim population of cultured human
foreskin keratinocytes (O’Shaughnessy et al, 2000), sug-
gesting PA-FABP as a marker for TAC. In our hands, freshly
prepared b1-integrin dim keratinocytes derived from adult
interfollicular epidermis displayed very low levels of this
molecule, again suggesting that cultured foreskin keratin-
ocytes differ from cultured adult keratinocytes. Although it
was demonstrated that PA-FABP can form a complex with
psoriasin (or S100A7), a member of the calcium binding
S100 protein family (Hagens et al, 1999a, b), no upregula-
tion of psoriasin was found in integrin dim cells (O’Shaugh-
nessy et al, 2000). Our results, however, show a strong
expression of psoriasin mRNA in psoriatic b1-integrin dim
keratinocytes. As psoriasin and PA-FABP were demonstrat-
ed to co-localize in differentiating keratinocytes of the
psoriatic lesion (Hagens et al, 1999a), our findings clearly
underline the strong commitment to differentiation in psoria-
tic b1-integrin dim cells. Similar results were found regarding
the expression levels of elafin. As expected, cultured normal
keratinocytes showed a marked upregulation of their initial
mRNA levels of all three molecules. Psoriatic dim cells
in vitro, on the other hand, displayed a downregulation of
the mRNA levels, suggesting a strong commitment toward
differentiation with an unexpected loss of the psoriatic phe-
notype. These results suggest a remarkable different phe-
notype of the psoriatic TAC compared with its normal
counterpart in vivo as well as in vitro. The defect noted in
vitro was maintained for the duration of the culture exper-
iment. The fact that the flow-sorted TAC-enriched fractions
were not capable of inducing regenerative maturation any-
more, despite their commitment to terminal differentiation,
was unexpected. Perhaps, this is because of the absence of
a hyperproliferative basal layer as shown by the low Ki-67
expression in vitro (Fig 3B), suggesting a loss of critical cell
communication necessary for the psoriatic phenotype.
One can speculate as to the cause of the psoriatic TAC
showing both loss of proliferative activity and regenerative
phenotype once cultured. Our data suggest that TAC from
psoriatic skin or the psoriatic b1-integrin dim subpopulation
are advanced in their life cycle compared with the b1-inte-
grin dim subpopulation derived from normal skin. We ex-
amined whether these subpopulations showed upregulation
of proteins involved in negative cell cycle control, as for
instance p16, p21, and p27. These cyclin-dependent kinase
(Cdk) inhibitory proteins are believed to block transition
from G1 to the S phase of the cell cycle, and it is discussed
whether upregulation of these proteins corresponds with a
state of keratinocyte senescence (Chaturvedi et al, 1999;
Sayama et al, 1999; Fu et al, 2003). More recently, the group
of Nickoloff demonstrated that the tumor suppressor
maspin is upregulated during keratinocyte senescence
(Nickoloff et al, 2004), and we included this marker in our
analysis. As expected, we found only low to undetectable
expression levels in freshly sorted keratinocytes, but with
the exception of p16, all expression levels remained low or
unchanged after culturing. p16 showed upregulation in all
normal and psoriatic subpopulations, with a marked in-
crease in the psoriatic bright subpopulation (Fig 8B). Ob-
viously, dim cells express higher levels of p16 when
cultured, but the highest level of p16 expression was not-
ed in the psoriatic bright subpopulation. Whether this
correlates with keratinocyte aging or with keratinocyte
senescence remains unclear, as evidence on p16 expres-
sion is conflicting. According to the work of Sayama, p16
appeared not to be associated with keratinocyte senes-
cence (Sayama et al, 1999). In fact, the work of Fu dem-
onstrated that although p16 showed upregulation in
senescent keratinocytes cultured under serum-free condi-
tions, the p16 expression level stayed low in keratinocytes
cultured on feeders (Fu et al, 2003), suggesting that p16
expression is sensitive to culture conditions and probably
not the ideal marker for senescence. Culture stress could be
another factor, but this does not seem plausible as the ex-
pression of elafin, a keratinocyte marker induced by various
forms of stress, showed an increase in normal keratin-
ocytes, but it remained low in both the psoriatic bright and
the dim cells (Fig 5B).
Obviously, there must be a tightly regulated balance be-
tween SC self-renewal and the generation of TAC that un-
dergo a limited number of more rapid (amplifying) transit
divisions before giving rise to postmitotic, terminally differ-
entiating cells. It is generally believed that a subpopulation
of SC resting in G0 exists, which can enter the cell cycle
when activated (Boezeman et al, 1987; Bickenbach and
Dunnwald, 2000). It has always been assumed that the cells
in the G0 phase of the cell cycle were SC, but no direct
evidence to prove this hypothesis has been published.
Dunnwald et al (2003) have shown that mouse SC are cy-
cling and not held out of the cell cycle as previously as-
sumed. It is generally accepted that as soon as cells leave
the SC compartment, they are committed to terminal dif-
ferentiation, and this process is considered to be continu-
ous and irreversible. In tape-stripped normal skin, however,
the recruitment of quiescent cells originates in part from the
layers above the basal cells, and in clinical clearance–re-
lapse studies in psoriatic skin the expression of the Ki-67
antigen after relapse was even exclusively suprabasal
(Rijzewijk et al, 1992; Castelijns et al, 1999). These studies
suggest that there is an exclusive cell kinetic control point at
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the level of the TAC. SC have an unlimited capacity for self-
renewal and continuously generate TAC at a slow rate (long
cell cycle time). On the other hand, the TAC in normal skin
can either become quiescent (resting in G0) at a specific
restriction point, or proliferate rapidly for a limited number of
cell divisions (short cell cycle time). In this way, a tissue can
regulate cell production, and the production rate can be
adapted on demand. The data presented in this study sug-
gest an abnormality in the recruitment of cells from the
transit amplifying specific restriction point in psoriatic ep-
idermis, resulting in a different age distribution that is main-
tained in vitro. A better characterization of the epidermal
germinative cell populations and the mechanisms involved
in its regulation should lead to a better understanding of
various hyperproliferative skin disorders such as psoriasis.
Materials and Methods
Biopsy procedure Normal epidermis was obtained from residual
human skin from abdominoplasty in healthy individuals. Pieces of
skin from about 4 cm2 were taken from the residual skin and kept in
MEM (Eagle, 25 mM Hepes with Earle’s salts, without glutamine,
Gibco BRL, Life Technologies, Grand Island, New York) with 1%
vol/vol antibiotic–antimycotic solution (Gibco) for a maximum of 7 d
at 41C. Four millimeter punch biopsies were taken from this ma-
terial. Additionally, 4 mm punch biopsies were obtained from
psoriatic patients who did not receive topical treatment for at least
1 wk. In order to obtain sufficient cell numbers, each sample con-
sisted of biopsies of four different patients. All psoriatic and sur-
gical patients gave their written informed consent. Biopsies were
kept in MEM with 10% vol/vol antibiotic–antimycotic solution for
2 h at 41C before cell isolation procedures. The study was con-
ducted according to the Declaration of Helsinki Principles. The
medical ethical committee of the Radboud University Nijmegen
approved all described studies.
Cell isolation and labeling procedure Biopsies were incubated
overnight in PBS containing 2.5 mg per mL trypsin (trypsin 250,
Difco Laboratories, Detroit, Michigan) at 41C, as described previ-
ously (van Rossum et al, 2002). Ten percent fetal calf serum (Harlan
Sera-Lab, Loughborough, UK) was added to stop trypzination and
the epidermis and dermis were separated with pincers. The ep-
idermal side of the dermis was gently scraped to ensure detach-
ment of basal cells. Both the epidermis and dermis were mixed on
a vortex to allow detachment of all keratinocytes. Subsequently,
the remaining stratum corneum and dermis were removed and the
cells were pelleted. The cells were resuspended and labeled with
K20-fluorescein isothiocyanate (FITC) (DAKO A/S, Glostrup, Den-
mark), an antibody directed against b1-integrin at a dilution of 1:20
for 45 min at 41C. Next, the cell suspension was washed with 1%
fetal calf serum/PBS and pelleted again. Finally, the cells were
resuspended in medium and sorted.
Cell sorting The labeled cell suspensions were sorted on an EP-
ICS Elite flow cytometer (Coulter, Luton, UK). A bandpass filter of
515–535 nm (green, FITC) was used to measure emitted light, while
a gate in the right angle scatter (a measure of regularity) versus the
forward scatter (a measure of size) was used to exclude debris.
Gates in the mean FITC fluorescence versus the forward scatter
were used to distinguish b1-integrin-negative and b1-integrin-pos-
itive cells. Of the b1-integrin-positive population, next the 10% cells
with the lowest mean FITC fluorescence were defined as b1-inte-
grin dim cells and the 10% cells with the highest mean FITC flu-
orescence were regarded as b1-integrin bright cells (Fig 1). After
sorting, cells were collected for either mRNA isolation of freshly
sorted cells, or otherwise seeded for culture experiments. In each
experiment, a six-well plate was filled with 20,000 cells per well,
with either b1-integrin dim cells, b1-integrin bright cells, or as a
control a subset of the b1-integrin-positive cells.
Cell culture Sorted keratinocytes were seeded on lethally irradi-
ated (3000 rad, 5 min) Swiss mouse 3T3 fibroblasts according to
the Rheinwald–Green system (Rheinwald and Green, 1975). The
cells were cultured in DMEM/F12 (3:1, vol/vol, Bio Whittaker,
Walkersville, Maryland) containing 0.4 mg per mL hydrocortisone
(Brunschwig Chemie BV, Amsterdam, the Netherlands), 106 M
isoproterenol (Sigma, St Louis, Missouri), 100 i.u. per mL penicillin
and 100 mg per mL streptomycin (Gibco), 6% fetal calf serum
(Harlan Sera-Lab), and 10 ng per mL epidermal growth factor
(Sigma). The six-well plates were kept in an incubator with 8% CO2
in the air and at 371C and 95% humidity.
Immunocytochemistry and ﬂow cytometric analysis For
immunocytochemical examination, parts of the sorted cells were
cultured on tissue culture coverslips (Thermanox, ICN Biomedicals
Inc., Aurora, Ohio). Approximately 7 d after seeding, colonies were
visible and at an early (14 d) and late time point (21 d) coverslips
were harvested for immunocytochemistry. Cells cultured on cover
slips were fixed using 100% ice-cold acetone. Before usage, the
coverslips were washed with excessive PBS. After blocking with
PBS containing 50% normal rabbit serum, coverslips were incu-
bated for 1 h with the following primary antibodies: anti-keratin
10 (RKSE60, Monosan, Uden, the Netherlands), anti-keratin 6
(LHK6B, Monosan) MIB-1 (Ki-67, DAKO A/S), anti-b1-integrin
(CD29; clone K20, DAKO A/S, and clone 4B4, Beckman Coulter
BV, Mijdrecht, the Netherlands), anti-a6-integrin (CD49f, Inst-
ruchemie, Delfzijl, the Netherlands), anti-collagen VII (Clone
LH7.2, Novocastra Laboratories, New Castle upon Tyne, UK), an-
ti-transferrin receptor (CD71, Immunotech, Marseille, France), and
anti-p63 (clone 7JUL, Novocastra Laboratories). After a washing
step, coverslips were incubated for 20 min with rabbit anti-mouse
immunoglobulins (DAKO A/S) and subsequently with mouse PAP
(DAKO A/S). After a washing step, coverslips were incubated by
diaminobenzidine (DAB, liquid DABþ large volume substrate-
chromogen solution, DAKO A/S) for 2 min and incubating the cov-
erslips in demineralized water terminated the reaction. Finally,
coverslips were mounted in glycerol gelatin (Sigma) without coun-
ter-staining.
In order to obtain quantitative data, we performed flow cyto-
metric measurements of the markers mentioned previously. For
this reason, another fraction of the sorted cells was cultured in six-
well plates as described above and harvested at approximately
60% and 100% confluency. Cells were trypsinized, and subse-
quently one fraction was fixed in 70% ice-cold ethanol and stored
at 201C until staining procedures, whereas another portion was
measured unfixed. Antibodies were directly labeled or otherwise
labeled using a Zenon One labeling kit containing R-phycoerythrin
(orange, R-PE) or Alexa Fluor 488 (green, Molecular Probes, Eu-
gene, Oregon). Antibodies directed against keratin 10 (RKSE60),
keratin 6 (LHK6B), and p63 (7JUL) were obtained from Monosan.
Antibodies against Ki-67 (Ki-67-RPE) and b1-integrin (CD29-FITC;
clone K20) were purchased from DAKO A/S. Antibodies against b1-
integrin (clone 4B4-PE, Beckman Coulter BV), a6-integrin (CD49f-
FITC, Instruchemie), b4-integrin (CD104-FITC, Kordia Life Sciences
BV, Leiden, the Netherlands), collagen VII (LH7.2, Novocastra Lab-
oratories), and transferrin receptor (CD71-PE, Immunotech) were
obtained as listed.
Real-time quantitative PCR Extraction of mRNA of both freshly
sorted and cultured human keratinocytes, followed by the gener-
ation of first-strand cDNA, was performed as described previously
(Zeeuwen et al, 2001). The reverse transcriptase reaction products
were used for quantitative real-time PCR amplification, which was
performed with the MyiQ Single-Color Real-Time Detection Sys-
tem for quantification with Sybr Green and melting curve analysis
(Biorad, Richmond, California). Primer sequences for a6-integrin,
b1-integrin, b4-integrin, CD71, collagen VII, keratin 10, keratin 6,
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Ki-67, p63, PA-FABP, psoriasin, SKALP/elafin, p16, p21, p27, ma-
spin, and the housekeeping gene human acidic ribosomal protein
P0 (hARP) are depicted in Table I. All primers were obtained from
Biolegio (Biolegio BV, Malden, the Netherlands). DNA was PCR-
amplified under the following conditions: 2 min at 501C and 10 min
at 951C followed by 40 cycles of 15 s at 951C and 1 min at 601C,
with data collection in the last 30 s. For all PCRs, iQ SYBR Green
Supermix (Biorad) was used in the reaction. All primer concentra-
tions were 300 nM in a total reaction volume of 25 mL. PCR re-
actions were performed in duplicate. The amount of each mRNA in
both keratinocyte subpopulations was normalized to the amount of
hARP in the same sample. Relative mRNA expression levels of all
examined genes were measured using the comparative 2DDCT
method (Livak and Schmittgen, 2001).
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